
Moderna Halts Vaccine Trial Over ‘Adverse Event’
Published on November 22, 2023
Moderna halted a clinical trial for a new vaccine because one of the participants suffered an adverse event, The Epoch Times has confirmed. Workers at two of the trial sites said the trial for the Epstein-Barr virus vaccine, which launched in early 2022, was paused. One of the workers said the trial was halted due to an issue with one of the participants. “We received an update about an adverse event that initiated the pause for dosing, but I, myself did not receive details on what the event was,” Maurice Beck, recruitment manager for Tekton Research, told The Epoch Times via email....
